title: Monitoring of a baby with neonatal hypothyroidism after maternal exposure to propylthiouracil.
authors.forename: Clara
authors.initials: C
authors.lastname: Naggara
authors.forename: Marie-Andrée
authors.initials: MA
authors.lastname: Bos-Thompson
authors.forename: Renaud
authors.initials: R
authors.lastname: Mesnage
authors.forename: Aude
authors.initials: A
authors.lastname: Mariani-Ecochard
authors.forename: Dominique
authors.initials: D
authors.lastname: Hillaire-Buys
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Blayac
authors.forename: Gilles
authors.initials: G
authors.lastname: Cambonie
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D007231:Infant, Newborn; D018811:Maternal Exposure; D008991:Monitoring, Physiologic; D011247:Pregnancy; D011441:Propylthiouracil / Q000008:administration & dosage / Q000009:adverse effects*; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000097:blood; D013974:Thyroxine / Q000627:therapeutic use; D014427:Twins
chemical_list: D013956:Antithyroid Agents; D013963:Thyroid Hormones; D011441:Propylthiouracil; D013974:Thyroxine